Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116768904B reveals high-yield chiral synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with superior enantioselectivity.
Novel metal-free route for spiro-chroman-4,3'-oxindole using 2,5-dimethylfuran. Enhances supply chain reliability and reduces heavy metal contamination risks.
Novel Ni-catalyzed asymmetric synthesis offers high yield and enantioselectivity for pharmaceutical intermediates, ensuring supply chain stability.
Patent CN115677456B reveals enzyme-catalyzed cannabidiol synthesis offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN113307790B reveals a metal-free oxidative cyclization for high-purity 1,2,4-triazole derivatives, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115385916B reveals high-yield chiral synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering scalable solutions for reliable pharmaceutical intermediate suppliers.
Patent CN101735134A details a high-yield enantioselective cyclization method. Offers cost-effective routes for optically pure tetrahydropyrrole drugs.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with reduced costs and enhanced supply chain reliability for global pharmaceutical partners.
Patent CN113121472A reveals a room-temperature gold catalysis method for N-sulfonyl pyrrolidines, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel visible-light catalytic ruthenium complex enables efficient alkyne-aldehyde addition. Reduces energy costs and simplifies purification for pharmaceutical intermediate manufacturing.
Novel one-pot Rh(III) catalysis for nitrogen heterocycles. High yield, mild conditions, cost-effective supply chain solution.
Patent CN105732631A reveals efficient N9 vinyl purine synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with high yield and scalability.
Novel metal-free visible light catalytic method for 1,2,3,4-tetrahydronaphthalene intermediates. Offers high atom utilization and mild conditions for pharma manufacturing.
Patent CN115785122A reveals a novel Lewis acid-catalyzed route to indole-piperidine scaffolds with high diastereoselectivity and potent MCF-7 cytotoxicity, offering a scalable solution for API manufacturing.
Novel copper-catalyzed method for high-purity pharmaceutical intermediates. Reduces steps and enhances supply chain reliability for global buyers seeking scalable solutions.
Novel Lewis acid catalyzed method for Meloxicam synthesis reduces reaction time and improves purity. Ideal for reliable pharmaceutical intermediate supplier partnerships.
Patent CN118878543A reveals high-purity axial chiral synthesis with significant PC-3 cytotoxic activity and scalable catalytic asymmetric methods for supply chain optimization.
Patent CN110467555B details a chiral phosphoric acid catalyzed method for high-purity axial chiral aryl indoles, offering cost-effective routes for oncology drug development.
Patent CN114160206B reveals a novel chiral copper catalyst enabling high-yield, enantioselective synthesis of indole intermediates with superior purity and scalability.